• Working Hours - Mon - Thu: 8:00 - 17:00; Fri: 8:00 - 14:00
What are you looking for?

Category Archives: News And Articles

World TB Day 2025: IHVN Participates in TB Awareness Activities

As part of activities to observe World Tuberculosis (TB) Day 2025, the Institute of Human Virology Nigeria (IHVN) has participated in events aimed at raising awareness and combating the TB epidemic in Nigeria.

Along with the National Tuberculosis, Leprosy and Buruli Ulcer Control Program (NTBLCP) and other stakeholders, IHVN took part in a road walk in Abuja, a community outreach program and a ministerial press briefing in Abuja.

At the Ministerial Press Briefing, IHVN Senior Information Education and Communications Manager, Ms. Uzoma Nwofor said that “For over 20 years, the Institute of Human Virology Nigeria (IHVN) has remained a formidable partner in Nigeria’s fight against TB and HIV. Since 2019, IHVN has played a pivotal role in expanding TB case detection through private healthcare provider engagement, rapid diagnostics, and community-based interventions.”

She emphasized the need for collaboration and  added that “Through the Global Fund-supported grant (2021–2023), IHVN optimized over 400 GeneXpert diagnostic sites and facilitated the deployment of other rapid molecular diagnostic platforms nationwide. Under the current Global Fund Grant Cycle 7 (2024–2026), we are supporting the deployment of over 190 portable digital X-ray systems enabled with artificial intelligence for TB screening in high-burden areas. Between 2021 – 2024 alone, IHVN-supported facilities tested over 3.5 million individuals, leading to the detection and notification of more than 350,000 TB cases, significantly contributing to Nigeria’s national case notification targets.”

IHVN also joined in an awareness campaign to  Sauka Community along Airport Road in Lugbe where Nigeria’s First Lady, Senator Oluremi Tinubu, pledged an additional ₦1 billion to combat TB in Nigeria, reaffirming her commitment to ending the disease by 2030.

“The statistics from the World Health Organization’s 2024 Global TB Report are alarming. In Nigeria, one person dies of TB every seven minutes. I will continue to advocate for increased funding and policy reforms to strengthen TB control efforts, as well as mobilize resources and partnerships to support TB awareness and treatment programs,” she stated.

Since 2019, IHVN has played a pivotal role in expanding TB case detection through private healthcare provider engagement, rapid diagnostics, and community-based interventions. Under the Global Fund-supported 2024–2026 Grant, IHVN continues to expand its community-based TB case-finding efforts, deploying active case-finding teams in rural and underserved areas. These teams, composed of community health workers, mentor mothers, and sample movers, facilitate screening, sample collection, and transportation to diagnostic centers, ensuring that no patient is left behind.

IHVN Celebrates March Employees of the Month

In fostering an excellent work culture and staff performance, the Executive Management of the Institute of Human Virology Nigeria (IHVN) has initiated the “Employee Recognition Awards” to recognize “Employees of the Month” and “Employee of the Year.”

According to the IHVN Director of Finance and Administration, Mr. Olu Alabi, this recognition covers overall employee performance in dressing, innovation, teamwork, productivity, efficiency, leadership and interpersonal skills, punctuality, and adherence to company values and principles, amongst other things.

For March 2025, IHVN Celebrates, Bello Zayyan Mohammed, Saheedat Ibrahim, Onyekachi Nwanyanwu, Daniel Ossom and Paschal Lojah whose performance stood out in their teams.

Three hearty cheers to our March star performers!

IHVN, PLASU Discuss Partnership in Medical Education

The Institute of Human Virology Nigeria (IHVN) and Plateau State University, Bokkos have met to discuss partnership in research and medical laboratory science education.

At the meeting which held at the IHVN Campus in Abuja, PLASU Acting Vice Chancellor, Prof. Shadrack Best said that the courtesy visit to the Institute is in furtherance of their desire to learn and embrace best practices in virology.

“We run academic programs, we do research, we have laboratories seeking upgrade and transformation in tandem with modern health practices. We are growing and very ambitious as we grow. We are looking for people to hold our hands. Particularly, we have a Faculty of Medical Sciences with degree programs in nursing, medical laboratory science and public health. It is becoming a stepping stone to our medical program because we intend to receive our pioneer medical students in October or November this year.”

Prof. Best requested for support for the university’s medical laboratory program in terms of equipment and internship or mentorship of its students. He thanked the IHVN CEO, Dr. Patrick Dakum for his diligent service in improving the health of Nigerians.

While welcoming the guests, Dr. Dakum said that the Institute is committed to its mission of being a center of excellence in capacity building, research and ensuring equitable access to quality health services through innovative and evidence-based services.

He traced the Institute’s long-standing relationship with Plateau State since inception and the establishment of the Plateau State Human Virology Research Center (PLASVIREC) named after the co-discoverer of the HIV virus and founder of the Institute of Human Virology, Baltimore, Prof. Robert Gallo.

Dr. Dakum stated that IHVN is providing technical support to PLASVIREC.  

“PLASVIREC is already doing some research and it will be best fit for the research arm of your medical school.”

He expressed the willingness of the Institute to partner in equipping students with skills in laboratory equipment maintenance, quality assurance and grant applications.

Also present at the meeting was PLASU Head of Internal Administration Vice Chancellor’s Office, Yitkyim Datong, IHVN Director Special Projects, Dr. Aderonke Agbaje, IHVN Technical Advisor, Mr. Abubakar Abdullahi and Coordinator of the International Research Center of Excellence (IRCE), Dr. Evaesi Okpokoro amongst others.

IHVN Celebrates February Employees of the Month

In fostering an excellent work culture and staff performance, the Executive Management of the Institute of Human Virology Nigeria (IHVN) has initiated the “Employee Recognition Awards” to recognize “Employees of the Month” and “Employee of the Year.”

According to the IHVN Director of Finance and Administration, Mr. Olu Alabi, this recognition covers overall employee performance in dressing, innovation, teamwork, productivity, efficiency, leadership and interpersonal skills, punctuality, and adherence to company values and principles, amongst other things.

For February 2025, IHVN Celebrates, Ademola Blessing Ajayi, Temitope Olukomogbon, Vincent Emmanuel, Kwaghe Kwalgha Jonah, Stanley Idakwo, Chigolum-Chidi David-Onuoha.

Abubakar Iliyasu Bichi and Paschal Lojah whose performance stood out in their teams.

Three hearty cheers to our February star performers!

World TB Day 2025: IHVN Expresses Commitment to Ending TB in Nigeria

The Institute of Human Virology Nigeria (IHVN) has expressed its continued commitment to ending tuberculosis in Nigeria through the expansion of tuberculosis (TB) case detection, community-based interventions and leveraging digital innovation.

Project Director of the Global Fund Tuberculosis and HIV Grant at the Institute, Dr. Olayemi Olupitan stated this at the pre-World TB Day press briefing in Abuja. She said that the Institute utilized Global Fund support from 2021 -2023 to optimize over 400 Gene Xpert diagnostic sites and is currently supporting the deployment of more than 190 portable digital Xray systems enabled with artificial intelligence for TB screening in high burden areas.

“Between 2021-2024 alone, IHVN-supported facilities tested 3.5 million individuals leading to the detection and notification of more than 350,000 tuberculosis cases, contributing to the country’s national case notification targets. The integration of digital screening tools, such as the Mobile Application for TB Screening (MATS), has further enhanced TB reporting from the private sector.”

Dr. Olupitan explained that the public-private partnership initiative championed by the Institute has resulted in capacity building and engagement of 15,000 patent and proprietary medicine vendors, 1000 pharmacists, 4,000 private hospitals and faith-based clinics and 1000 traditional healers and birth attendants in tuberculosis diagnosis, treatment and community screening.

“Under the Global Fund 2024-2026 Grant, strengthening TB and HIV integration is a key priority. In 2024 alone, over 270,000 pregnant women were screened for TB and HIV in both community settings and unconventional sites enabling early diagnosis and initiation of prevention therapy were necessary.”

Also at the press briefing, the Executive Secretary of the Global Fund Country Coordinating Mechanism, Mr. Ibrahim Tajudeen stressed the need for sufficient funding to address tuberculosis in Nigeria.

Stakeholders at the briefing including the Chairman of the House Committee on HIV/AIDS, Tuberculosis and Malaria, Mr. Amobi Ogah, Director of Public Health, Dr. Godwin Ntadom, Representative of the World Health Organization in Nigeria, Dr. Mya Sapal and the Acting Board Chairman of Stop TB Partnership in Nigeria, Dr. Queen Ogbuji, all assured Nigerians of their commitment to ending tuberculosis in Nigeria.

According to the 2024 World Health Organization Global Tuberculosis Report, Nigeria ranks first in Africa and sixth globally among the 30 high burden tuberculosis countries. The theme for this year’s commemoration is “Yes! We Can End TB – Commit, Invest, Deliver.  Apart from press-briefings, other activities to commemorate the day include, community outreach and sensitization activities and a road show.